ActRight

The easy access to improved healthcare facilities and the growing insurance penetration rate under the mandatory health insurance (MHI) schemes are primarily driving the GCC in-vitro diagnostic devices market. Additionally, the increasing prevalence of chronic diseases, on account of the unhealthy diets and sedentary schedules of individuals, and the rising number of consumers seeking diagnostic services at regular intervals to avoid these conditions are further stimulating the market growth.